RegStem

Description: RegStem develops regenerative medicine drugs, licensing innovative molecules for human therapies after clinical trials.

Country: France

Based in: Paris

Founded: 2017

Funding Stage: Seed

Tags: ['innovative biotechnology', 'biopharmaceutical', 'life science']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.